Insights on Global Blood Transfusion Diagnostics Market and Forecast Assumptions for the Period 2017 - 2025

A new research study titled “Blood Transfusion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025” has been added to the vast repository of Market Research Reports Search Engine (MRRSE). According to the report, the global blood transfusion diagnostics market is likely to reach a valuation of over US$ 5.5 Bn by 2026.

Get Free Sample Report @ https://www.mrrse.com/sample/3375

Blood transfusion diagnostics include instruments such as analyzers and centrifuges, and kits & reagents used for various tests such as blood grouping and disease screening for donors as well as patients. Blood screening is a major step in the pre-transfusion process. The report on the global blood transfusion diagnostics market analyzes the current and future prospects of the market. The report consists of an executive summary that provides information about the products, its segments and sub-segments, along with a market snapshot and comparative analysis by region, in terms of revenue %, for 2016.

A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the blood transfusion diagnostics market, along with Porter’s Five Forces Analysis, of the global market has been provided in this report. Market revenue analysis for all the above mentioned segments and sub segments has been provided for the forecast period from 2017 to 2025, considering 2016 as the base year and 2015 as the historical year, along with compound annual growth rate (CAGR %) for the forecast period from 2017 to 2025. Market share estimations were based on in-depth analysis and study of products, and their features, prices, etc.

Increase in shift toward automation in blood banks is likely to benefit blood collection facilities due to reduced turnaround time for test completion and overcoming the shortage of workforce required to conduct the requisite tests. Deployment of automated systems is anticipated to help these facilities to reorganize workflow and increase efficiency. Rise in demand for blood and blood components transfusions owing to large patient population suffering from chronic diseases such as aplastic anemia, sickle cell anemia, and leukemia is the major factor driving the blood transfusion diagnostics market. According to estimates provided by the American Cancer Society, nearly 62,130 new cases of leukemia were reported in the U.S. alone in 2017. According to Centers for Disease Control and Prevention (CDC) estimates, 100,000 people are affected by sickle cell disease in the U.S. each year. Rise in incidence of chronic diseases presents large patient population requiring blood transfusions. This is expected to drive demand for blood transfusions, leading to increase in demand for transfusion diagnostic instruments, kits, and reagents.

Browse Complete Report with TOC @ https://www.mrrse.com/blood-transfusion-market

Based on product type, the global blood transfusion diagnostics market has been segmented into instruments and kits & reagents. In terms of application, the global market has been categorized into blood grouping and disease screening. Disease screening has been classified into molecular disease screening and serological disease screening. Based on end-user, the global blood transfusion diagnostics market has been divided into hospitals, diagnostic laboratories, blood banks, plasma fractionation companies, and others.

In terms of region, the global blood transfusion diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further segmented into major countries and sub-regions such as the U.S., Canada, Germany, the U.K., France, Italy, Spain, Rest of Europe, China, Japan, India, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, Saudi Arabia, South Africa, and Rest of MEA. The report also comprises a list of major players in the market, their SWOT analysis, market share of these players in the blood transfusion diagnostics market, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include Grifols S.A., Immucor Inc., Bio-Rad Laboratories Inc., Abbott, DiaSorin S.p.A., Ortho Clinical Laboratories, Quotient Limited, and F. Hoffman-La Roche Ltd.

The global blood transfusion diagnostics market has been segmented as follows:

Global Blood Transfusion Diagnostics Market, by Product
Instruments
Kits & Reagents
Global Blood Transfusion Diagnostics Market, by Application
Blood Grouping
Disease Screening
Molecular Disease Screening
Serological Disease Screening
Global Blood Transfusion Diagnostics Market, by End-user
Hospitals
Diagnostic Laboratories
Blood Banks
Plasma Fractionation Companies
Others
Global Blood Transfusion Diagnostics Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
Rest of MEA

About MRRSE

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street Suite 700
Albany, NY – 12207 (United States)
Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/

This release was published on openPR.